November 9-11, 2020 | Virtual Conference

Speakers

Tao Bai, PhD

Lead Pharmacologist, Division of Bioequivalence I, Office of Bioequivalence (OB), OGD, CDER
FDA

Dr. Tao Bai is a Lead Pharmacologist and a Team Leader in Office of Bioequivalence (OB) in Office of Generic Drugs (OGD). In her current role, she coordinates all COVID-19 related scientific inquiries submitted to OGD and provide her professional input to ensure an efficient and consistent response to these inquiries in a timely fashion. Prior to joining FDA in 2010, Dr. Bai was a postdoctoral Research Fellow at University of Maryland School of Pharmacy studying Nasal and Inhalation Drug Products. She received her Ph.D. in Pharmaceutical Sciences from University of Maryland.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content